Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV815, targeting neurological disorders connected to the kinesin-family of proteins. To bolster its research and development efforts, Ovid maintains licensing and collaborative agreements with prominent entities such as Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Marinus Pharmaceuticals, Inc. Established in 2014, the company's corporate headquarters are situated in New York, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Ovid Therapeutics Inc.
NASDAQ:OVIDHealthcare · Biotechnology
-0.23%$2.15
AH Close$2.15-0.18%vs close
AH Close$2.15-0.18%vs close
Mkt Cap$420.87M
Float176.49M
O/S195.3M
Inst Own75.3%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$7.25M
Net Income-$17.41M
Total Assets$150.93M
Free Cash Flow-$38.33M
Debt & Equity
Debt 9%
Equity 91%
Total Debt$13.42M
Total Equity$130.66M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in OVID's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$150.93M
Liabilities$20.27M
Accounts Receivable$0
Accounts Payable$1.96M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $7.25M | $566K | $392K | $1.5M | $208.38M | $12.62M | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 1181.3% | 44.4% | -73.9% | -99.3% | 1551.6% | - | - | - | - | - | - | - |
| Cost of Revenue | $300K | $0 | $0 | $0 | $0 | $0 | $0 | $142K | $80K | $0 | $12K | $0 |
| Gross Profit | $6.95M | $566K | $392K | $1.5M | $208.38M | $12.62M | $0 | -$142K | -$80K | -$57K | -$12K | $0 |
| Gross Margin | 95.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - | - | - | - | - | - |
| Research and Development | $25.58M | $36.77M | $28.59M | $24.62M | $46.94M | $64.12M | $46.86M | $33.79M | $49.97M | $9.59M | $6.61M | $105K |
| Selling, General, and Administrative | $24.11M | $25.68M | $29.59M | $32.43M | $37.23M | $30.63M | $19.25M | $19.14M | $15.04M | $12.95M | $6.58M | $342K |
| Other | -$300K | $1K | $1.5M | $510 | $1K | -$700K | -$4.7M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $49.39M | $62.45M | $59.67M | $57.05M | $84.17M | $94.05M | $61.41M | $52.93M | $65.01M | $22.54M | $13.19M | $447K |
| Operating Income (EBIT) | -$42.44M | -$61.88M | -$59.28M | -$55.55M | $124.21M | -$81.43M | -$61.41M | -$52.93M | -$65.01M | -$22.54M | -$13.19M | -$447K |
| Operating Margin | -585.2% | -10933.7% | -15122.7% | -3696.4% | 59.6% | -645.4% | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $3.9M | $4.9M | $0 | $0 | $395K | $948K | $952K | $202K | $0 | $30K | $0 |
| Other Income (Expense) | $25.02M | $35.45M | $6.94M | $1.38M | -$46K | $395K | $948K | $952K | $202K | $121K | $30K | $0 |
| Income Before Tax (EBT) | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $124.16M | -$81.04M | -$60.46M | -$51.98M | -$64.81M | -$22.41M | -$13.16M | -$447K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $1.33M | $0 | $0 | $0 | -$80K | -$950 | $0 | $0 |
| Net Income | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $122.83M | -$81.04M | -$60.46M | -$51.98M | -$64.81M | -$22.41M | -$13.16M | -$447K |
| Net Income Margin | -240.1% | -4670.1% | -13351.8% | -3604.7% | 58.9% | -642.3% | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||
| EPS | -0.24 | -0.37 | -0.74 | -0.77 | 1.78 | -1.39 | -1.51 | -2.11 | -3.35 | -1.14 | -0.67 | -0.09 |
| Diluted EPS | -0.24 | -0.37 | -0.74 | -0.77 | 1.76 | -1.39 | -1.51 | -2.11 | -3.35 | -1.14 | -0.67 | -0.09 |
| Weighted Average OS | 73.74M | 70.91M | 70.58M | 70.42M | 67.48M | 58.45M | 39.22M | 24.63M | 19.34M | 19.60M | 19.60M | 4.75M |
| EBITDA | -$17.14M | -$57.77M | -$57.01M | -$54.17M | $124.45M | -$81.12M | -$61.15M | -$52.79M | -$64.73M | -$22.48M | -$13.18M | -$445K |
| EBITDA Margin | -236.4% | -10207.1% | -14544.1% | -3604.5% | 59.7% | -643.0% | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $13.15M | $26.3M | $27.04M | $44.87M | $187.8M | $72.03M | $41.9M | $36.49M | $87.13M | $51.94M | $69.94M | $4.85M |
| Short-Term Investments | $56.48M | $26.77M | $78.79M | $84.13M | $0 | $0 | $34.84M | $5.01M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $69.64M | $53.08M | $105.83M | $129M | $187.8M | $72.03M | $76.74M | $41.5M | $87.13M | $51.94M | $69.94M | $4.85M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $142K | $1.13M | $0 | $0 | $7K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $243K | $0 | $0 |
| Other Current Assets | $20.81M | $0 | $1K | $1 | $2.68M | $0 | $0 | $600K | $0 | $243K | $59K | $0 |
| Total Current Assets | $90.45M | $55.94M | $109.6M | $131.38M | $190.48M | $74.84M | $79.81M | $44.27M | $88.59M | $52.41M | $70.28M | $4.85M |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $0 | $13.23M | $14.66M | $16.07M | $243K | $136K | $68K | $70K | $52K | $44K | $30K | $1K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $100 | -$247 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $92K | $200K | $222K | $164K | $319K | $467K | $392K | $124K | $110K | $19K | $3K |
| Long-Term Investments | $64.7M | $20.97M | $17.63M | $5.62M | $3.56M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | -$4.22M | $1.93M | $1.94M | $1.97M | $96K | $628K | $495K | $2.92M | $694K | $463K | $45K | $7K |
| Total Long-Term Assets | $60.49M | $36.23M | $34.43M | $23.89M | $4.07M | $1.08M | $1.03M | $3.38M | $870K | $617K | $93K | $10K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | -$100 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $150.93M | $92.17M | $144.03M | $155.27M | $194.54M | $75.93M | $80.84M | $47.65M | $89.46M | $53.03M | $70.38M | $4.86M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $1.96M | $3.19M | $3.7M | $1.95M | $7.13M | $5.45M | $3.26M | $3.76M | $2.03M | $857K | $671K | $79K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $2.21M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $1K | $0 | $0 | $3.91M | $8.19M | $4.55M | $2.31M | $2.08M | $0 | $0 | $0 |
| Total Current Liabilities | $8.29M | $10.52M | $11.47M | $6.99M | $14.8M | $22.06M | $10.53M | $8.84M | $6.02M | $3.73M | $2.31M | $120K |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $10.17M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $30M | $1 | $0 | $61K | $287K | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $11.99M | $13.42M | $44.76M | $16M | $0 | $10.23M | $287K | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $20.27M | $23.94M | $56.23M | $22.99M | $14.8M | $32.29M | $10.82M | $8.84M | $6.02M | $3.73M | $2.31M | $120K |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $1 | $1 | $3 | $8 | $0 | $0 | $8K | $17K | $5K |
| Common Stock | $130K | $71K | $71K | $70K | $70K | $66K | $55K | $25K | $25K | $20K | $21K | $20K |
| Retained Earnings | -$321.71M | -$304.3M | -$277.87M | -$225.53M | -$171.36M | -$294.19M | -$213.16M | -$152.7M | -$100.72M | -$61.77M | -$13.5M | -$335K |
| Comprehensive Income & Other | -$202K | -$35K | $0 | -$42K | $0 | $0 | $2K | -$2K | -$51K | -$20K | $0 | $0 |
| Other Stockholders' Equity | $452.24M | $372.45M | $365.59M | $357.73M | $351.03M | $337.76M | $283.13M | $191.48M | $184.13M | $111.05M | $81.54M | $5.05M |
| Total Equity | $130.66M | $68.23M | $87.8M | $132.27M | $179.75M | $43.63M | $70.02M | $38.81M | $83.44M | $49.29M | $68.07M | $4.74M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $150.93M | $92.17M | $144.03M | $155.27M | $194.54M | $75.93M | $80.84M | $47.65M | $89.46M | $53.03M | $70.38M | $4.86M |
| Supplementary Data | ||||||||||||
| Total Debt | $13.42M | $14.76M | $16M | $16.54M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | $266K | -$11.55M | -$11.04M | -$28.33M | -$187.8M | -$72.03M | -$41.9M | -$36.49M | -$87.13M | -$51.94M | -$69.94M | -$4.85M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$17.41M | -$26.43M | -$52.34M | -$54.17M | $122.83M | -$81.04M | -$60.46M | -$51.98M | -$64.81M | -$22.41M | -$13.16M | -$447K |
| Depreciation & Amortization | $273K | $613K | $568K | $1.38M | $237K | $307K | $255K | $142K | $80K | $57K | $12K | $2K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K | $0 | -$3.64M | $0 | $0 |
| Stock-Based Compensation | $4.81M | $6.28M | $7.29M | $6.56M | $5.05M | $7.53M | $5.21M | $7.06M | $6.4M | $3.64M | $1.46M | $33K |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $142K | $989K | -$531K | $0 | $7K | $50K | -$69K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$1.23M | -$512K | $1.75M | -$5.17M | $1.7M | $2.33M | -$654K | $1.65M | $1.08M | $187K | $591K | $0 |
| Other Working Capital | -$2.87M | $362K | $636K | -$3.06M | -$18.66M | $18.5M | $5.12M | -$2.44M | -$79K | $728K | $1.22M | $45K |
| Total Working Capital Change | -$4.1M | -$150K | $2.39M | -$8.23M | -$16.81M | $21.82M | $3.94M | -$788K | $997K | $914K | $1.81M | $45K |
| Other Non-Cash Items | -$21.9M | -$36.26M | -$3.68M | -$765K | $7.3M | -$199K | -$30K | -$1K | $25.86M | $3.64M | $4.39M | $106K |
| Net Cash from Operating | -$38.33M | -$55.96M | -$45.78M | -$55.23M | $118.61M | -$51.58M | -$51.09M | -$45.56M | -$31.47M | -$17.8M | -$5.49M | -$261K |
| Investing Activities | ||||||||||||
| Capital Expenditures | $0 | -$71K | -$40K | -$1.42M | -$184K | -$127K | -$57K | -$352K | -$47K | -$189K | -$56K | -$2K |
| Acquisitions | $0 | $0 | -$10M | -$2.5M | -$1.63M | $0 | $0 | $318K | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$91.85M | -$73.25M | -$112.44M | -$172.96M | $0 | -$9.96M | -$34.8M | -$50.01M | $0 | $0 | $0 | $0 |
| Sales of Investments | $42M | $128M | $120M | $90M | $0 | $45M | $5M | $45M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$89K | -$97K | -$1M | -$5K | -$263K | -$187K | -$318K | -$8K | -$159K | -$24K | -$4K |
| Net Cash from Investing | -$49.85M | $54.59M | -$2.58M | -$87.88M | -$1.82M | $34.65M | -$30.04M | -$5.36M | -$47K | -$189K | -$56K | -$6K |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | -$30M | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $75.21M | $622K | $535K | $181K | $925K | $46.73M | $86.41M | $286K | $69.75M | $0 | $70.64M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | -$21K | $341K | $132K | $286K | -$3.05M | -$14K | $0 | $6.73M |
| Net Cash from Financing | $75.21M | $622K | $30.54M | $181K | $904K | $47.07M | $86.54M | $286K | $66.7M | -$14K | $70.64M | $6.73M |
| Forex Effect | -$167K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$13.15M | -$740K | -$17.83M | -$142.93M | $117.69M | $30.14M | $5.41M | -$50.64M | $35.19M | -$18M | $65.1M | $6.46M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$38.33M | -$55.96M | -$45.78M | -$55.23M | $118.61M | -$51.58M | -$51.09M | -$45.56M | -$31.47M | -$17.8M | -$5.49M | -$261K |
| Capital Expenditure | $0 | -$71K | -$137K | -$1.42M | -$189K | -$391K | -$244K | -$352K | -$47K | -$189K | -$56K | -$2K |
| Free Cash Flow | -$38.33M | -$56.03M | -$45.92M | -$56.65M | $118.42M | -$51.97M | -$51.33M | -$45.91M | -$31.52M | -$17.99M | -$5.54M | -$263K |
| Cash at Beginning | $28.23M | $28.97M | $46.8M | $189.73M | $72.03M | $41.9M | $36.49M | $87.13M | $51.94M | $69.94M | $4.85M | $0 |
| Cash at End | $15.08M | $28.23M | $28.97M | $46.8M | $189.73M | $72.03M | $41.9M | $36.49M | $87.13M | $51.94M | $69.94M | $6.46M |